Background/Objectives: The objective of this study was to investigate associations between the spatial distribution of brain lesions and clinical outcomes in a cohort of people followed up 20 years after presentation with a clinically isolated syndrome (CIS) suggestive of multiple sclerosis (MS).
Methods: Brain lesion probability maps (LPMs) of T1 and T2 lesions were generated from 74 people who underwent magnetic resonance imaging (MRI) and clinical assessment a mean of 19.9 years following a CIS. One-tailed t-test statistics were used to compare LPMs between the following groups: clinically definite (CD) MS and those who remained with CIS, with an abnormal MRI; people with MS and an Expanded Disability Status Scale (EDSS) ≤3 and >3; people with relapsing–remitting (RR) and secondary progressive (SP) MS. The probability of each voxel being lesional was analysed adjusting for age and gender using a multiple linear regression model.
Results: People with CDMS were significantly more likely than those with CIS and abnormal scan 20 years after onset to have T1 and T2 lesions in the corona radiata, optic radiation, and splenium of the corpus callosum (periventricularly) and T2 lesions in the right fronto-occipital fasciculus. People with MS EDSS >3, compared with those with EDSS ≤3, were more likely to have optic radiation and left internal capsule T2 lesions. No significant difference in lesion distribution was noted between RRMS and SPMS.
Conclusion: This work demonstrates that lesion location characteristics are associated with CDMS and disability after long-term follow-up following a CIS. The lack of lesion spatial distribution differences between RRMS and SPMS suggests focal pathology affects similar regions in both subgroups.
PolmanCHReingoldSCBanwellBClanetMCohenJAFilippiM. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol. 2011; 69(2): p. 292–302.
2.
PolmanCHReingoldSCEdanGFilippiMHartungHPKapposL. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol. 2005; 58(6): p. 840–6.
3.
VellingaMMGeurtsJJRostrupEUitdehaagBMPolmanCHBarkhofF. Clinical correlations of brain lesion distribution in multiple sclerosis. J Magn Reson Imaging. 2009; 29(4): p. 768–73.
4.
SchreiberKSørensenPSKoch-HenriksenNWagnerABlinkenbergMSvarerC. Correlations of brain MRI parameters to disability in multiple sclerosis. Acta Neurol Scand. 2001; 104(1): p. 24–30.
5.
FisnikuLKBrexPAAltmannDRMiszkielKABentonCELanyonR. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain. 2008; 131(Pt 3): p. 808–17.
6.
KurtzkeJF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983; 33(11): p. 1444–52.
7.
van WalderveenMABarkhofFTasMWPolmanCFrequinSTHommesOR. Patterns of brain magnetic resonance abnormalities on T2-weighted spin echo images in clinical subgroups of multiple sclerosis: a large cross-sectional study. Eur Neurol. 1998; 40(2): p. 91–8.
8.
O’RiordanJILosseffNAPhatourosCThompsonAJMoseleyIFMacManusDG. Asymptomatic spinal cord lesions in clinically isolated optic nerve, brain stem, and spinal cord syndromes suggestive of demyelination. J Neurol Neurosurg Psychiatry. 1998; 64(3): p. 353–7.
9.
MinnebooABarkhofFPolmanCHUitdehaagBMKnolDLCastelijnsJA. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Arch Neurol. 2004; 61(2): p. 217–21.
10.
PoserCMPatyDWScheinbergLMcDonaldWIDavisFAEbersGC. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983; 13(3): p. 227–31.
11.
LublinFDReingoldSC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996; 46(4): p. 907–11.
12.
BodiniBBattagliniMDe StefanoNKhaleeliZBarkhofFChardD. T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry. J Neurol Neurosurg Psychiatry. 2011; 82(1): P72–7.
13.
PlummerDL. Dispimage: a display and analysis tool for medical images. Rev Neuroradiol. 1992; 5: p. 489–95.
14.
MoriSWakanaSNagae-PoetscherLMZijlPC. MRI atlas of human white matter2005; Elsevier: Amsterdam (The Netherlands).
15.
NicholsTEHolmesAP. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp, 2002; 15(1): p. 1–25.
16.
JafariNKreftKLFlachHZJanssensACHintzenRQ.Callosal lesion predicts future attacks after clinically isolated syndrome. Neurology. 2009; 73(22): p. 1837–41.
17.
AchironABarakY.Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry. 2003; 74(4): p. 443–6.
18.
KalronADvirZAchironA. Walking while talking–difficulties incurred during the initial stages of multiple sclerosis disease process. Gait Posture. 2010; 32(3): p. 332–5.
19.
MadlerBDrabyczSAKolindSHWhittallKPMacKayAL.Is diffusion anisotropy an accurate monitor of myelination? Correlation of multicomponent T2 relaxation and diffusion tensor anisotropy in human brain. Magn Reson Imaging. 2008; 26(7): p. 874–88.
20.
LauleVavasourIMMooreGROgerJLiDKPatyDW. Water content and myelin water fraction in multiple sclerosis. A T2 relaxation study. J Neurol. 2004; 251(3): p. 284–93.
21.
EichlerFMahmoodALoesDBezmanLLinDMoserHW. Magnetic resonance imaging detection of lesion progression in adult patients with X-linked adrenoleukodystrophy. Arch Neurol. 2007; 64(5): p. 659–64.
22.
KimTSKimIOKimWSChoiYSLeeJYKimOW. MR of childhood metachromatic leukodystrophy. AJNR Am J Neuroradiol. 1997; 18(4): p. 733–8.
23.
FarleyTJKetonenLMBodensteinerJBWangDD.Serial MRI and CT findings in infantile Krabbe disease. Pediatr Neurol. 1992; 8(6): p. 455–8.
24.
LeeMABlamireAMPendleburySHoKHMillsKRStylesP. Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis. Arch Neurol. 2000; 57(1): p. 65–70.
25.
Di PerriCBattagliniMStromilloMLBartolozziMLGuidiLFedericoA. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. Arch Neurol. 2008;65(2): p. 236–43.
26.
SombekkeMHVellingaMMUitdehaagBMBarkhofFPolmanCHArtetaD. Genetic correlations of brain lesion distribution in multiple sclerosis: an exploratory study. AJNR Am J Neuroradiol. 2011; 32(4): p. 695–703.
27.
CalabreseRoccaMAtzoriMAMattisiMFavarettoIPeriniAP. A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Ann Neurol. 2010;67(3): p. 376–83.
